AEON Stock Analysis: Buy, Sell, or Hold?
AEON - AEON Biopharma, Inc.
$0.98
-0.01 (-0.67%)
▼
5d:
-4.08%
30d:
-10.24%
90d:
-9.41%
HOLD
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: Mar 30, 2026
0d
Get Alerted When AEON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AEON shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: AEON shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: AEON is currently trading at $0.98, which is considered oversold relative to its 30-day fair value range of $1.03 to $1.17.
Technical Outlook: Technically, AEON is in a uptrend. The price is currently testing key support at $0.95. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AEON has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.20 (+635.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AEON is in a uptrend. The price is currently testing key support at $0.95. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AEON has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.20 (+635.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.03 -
$1.17
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 635.9% below Wall St target ($7.20)
Fair Price Analysis
30-Day Fair Range
$1.03 -
$1.17
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.95
Resistance Level
$1.33
Current Trend
Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.16
Wall Street Target
$7.20
(+635.9%)
Share & Embed Analysis
Last updated: April 02, 2026 7:25 AM ET
Data refreshes hourly during market hours. Next update: 8:25 AM
Data refreshes hourly during market hours. Next update: 8:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AEON showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 52 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 66 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 52 HOLD |
